menu
    • menu

    Company profile for Arcus Biosciences

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Arcus is an oncology-focused biopharmaceutical company leveraging its deep cross-discipline expertise to discover highly differentiated therapies and develop a broad portfolio of novel combinations addressing significant unmet needs. Arcus’s lead small molecule programs target the adenosine axis, which has been shown to play a significant role in driving immuno-suppression in the tumor micro-environment.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Arcus BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3928 Point Eden Way Hayward, CA 94545
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://arcusbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Arcus Updates Phase 3 STAR-221 Study, Focuses R&D On Casdatifan
    Arcus Updates Phase 3 STAR-221 Study, Focuses R&D On Casdatifan

    12 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-12/arcus-provides-update-on-phase-3-star-221-study-and-concentrates-its-rd-investment-on-casdatifan-an

    PHARMIWEB
    12 Dec 2025
    Share Share
    Arcus Biosciences Announces New Employment Inducement Grants
    Arcus Biosciences Announces New Employment Inducement Grants

    09 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251209457911/en/Arcus-Biosciences-Announces-New-Employment-Inducement-Grants

    BUSINESSWIRE
    09 Dec 2025
    Share Share
    Arcus Bio To Join Two Investor Conferences
    Arcus Bio To Join Two Investor Conferences

    18 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251118389291/en/Arcus-Biosciences-to-Participate-in-Two-Upcoming-Investor-Conferences

    BUSINESSWIRE
    18 Nov 2025
    Share Share
    Arcus Bio Sets Price For $250M Common Stock Offering
    Arcus Bio Sets Price For $250M Common Stock Offering

    30 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251030570538/en/Arcus-Biosciences-Announces-Pricing-of-%24250-Million-Public-Offering-of-Common-Stock

    BUSINESSWIRE
    30 Oct 2025
    Share Share
    Arcus Bio Initiates Public Common Stock Offering
    Arcus Bio Initiates Public Common Stock Offering

    30 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251030240477/en/Arcus-Biosciences-Announces-Commencement-of-Public-Offering-of-Common-Stock

    BUSINESSWIRE
    30 Oct 2025
    Share Share
    Arcus Bio Reveals Q3 2025 Financials And Pipeline Update
    Arcus Bio Reveals Q3 2025 Financials And Pipeline Update

    28 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251028605428/en/Arcus-Biosciences-Reports-Third-Quarter-2025-Financial-Results-and-Provides-a-Pipeline-Update

    BUSINESSWIRE
    28 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search